COMI, Cristoforo
 Distribuzione geografica
Continente #
EU - Europa 9.595
NA - Nord America 6.301
AS - Asia 5.043
SA - Sud America 922
AF - Africa 190
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
Totale 22.065
Nazione #
US - Stati Uniti d'America 6.129
RU - Federazione Russa 2.236
NL - Olanda 1.907
SG - Singapore 1.724
IE - Irlanda 1.502
CN - Cina 1.151
DE - Germania 869
IT - Italia 834
VN - Vietnam 735
HK - Hong Kong 704
BR - Brasile 699
SE - Svezia 623
UA - Ucraina 497
FR - Francia 355
FI - Finlandia 306
IN - India 192
GB - Regno Unito 174
CA - Canada 97
KR - Corea 93
AR - Argentina 87
BJ - Benin 78
ID - Indonesia 76
BD - Bangladesh 73
PL - Polonia 61
JP - Giappone 59
MX - Messico 55
EC - Ecuador 47
ZA - Sudafrica 44
CZ - Repubblica Ceca 43
AT - Austria 39
ES - Italia 34
TR - Turchia 33
IR - Iran 30
IQ - Iraq 29
BE - Belgio 27
CO - Colombia 23
LT - Lituania 23
GR - Grecia 21
PY - Paraguay 21
MA - Marocco 17
SA - Arabia Saudita 17
PH - Filippine 14
PK - Pakistan 14
CL - Cile 13
UZ - Uzbekistan 13
EG - Egitto 12
IL - Israele 12
PE - Perù 11
VE - Venezuela 11
DZ - Algeria 10
AE - Emirati Arabi Uniti 9
EU - Europa 9
RO - Romania 9
AZ - Azerbaigian 8
KE - Kenya 8
KZ - Kazakistan 7
NP - Nepal 7
UY - Uruguay 7
LB - Libano 6
AL - Albania 5
CH - Svizzera 5
JO - Giordania 5
KW - Kuwait 5
LV - Lettonia 5
SN - Senegal 5
TH - Thailandia 5
TN - Tunisia 5
TW - Taiwan 5
BG - Bulgaria 4
DO - Repubblica Dominicana 4
PA - Panama 4
AU - Australia 3
DK - Danimarca 3
JM - Giamaica 3
OM - Oman 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
ET - Etiopia 2
GA - Gabon 2
HN - Honduras 2
LK - Sri Lanka 2
MY - Malesia 2
PT - Portogallo 2
QA - Qatar 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DM - Dominica 1
EE - Estonia 1
GD - Grenada 1
GM - Gambi 1
IS - Islanda 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 22.050
Città #
Amsterdam 1.891
Dublin 1.500
Jacksonville 864
San Jose 772
Hong Kong 697
Singapore 642
Ashburn 437
Dearborn 435
Beijing 337
Moscow 283
Ho Chi Minh City 232
Los Angeles 223
Lauterbourg 214
Chandler 213
Wilmington 200
Lawrence 180
Princeton 180
Hanoi 138
San Mateo 111
New York 107
Buffalo 102
Ann Arbor 98
Munich 98
Piemonte 95
Milan 92
Seoul 86
Cotonou 78
São Paulo 74
Dallas 73
Andover 72
Helsinki 72
Boardman 68
Orem 68
Novara 67
Turin 59
Santa Clara 55
Dong Ket 52
Rome 52
Warsaw 47
Bremen 45
Chennai 44
Denver 42
Tokyo 42
Council Bluffs 39
Falkenstein 39
Brno 38
Houston 38
Redondo Beach 38
Frankfurt am Main 37
Nuremberg 37
Toronto 37
Jakarta 36
Da Nang 34
Monmouth Junction 34
Woodbridge 34
Guangzhou 33
Hefei 31
Johannesburg 31
Tianjin 30
Brooklyn 29
Chicago 29
Grafing 29
London 29
St Louis 28
Hangzhou 27
Manchester 27
Poplar 27
Turku 27
Brussels 26
Mumbai 26
Stockholm 26
Torino 26
Strasbourg 25
Atlanta 24
Montreal 24
Nanjing 24
Phoenix 24
Boston 23
Haiphong 23
Seattle 23
Düsseldorf 22
Guayaquil 21
Mexico City 20
Rio de Janeiro 19
Vienna 19
Belo Horizonte 18
Mülheim 18
Ankara 17
Norwalk 17
Vercelli 17
Shanghai 16
Dhaka 15
Fairfield 15
Hải Dương 15
Kunming 15
Alessandria 14
Biên Hòa 14
Porto Alegre 14
Jinan 13
Quito 13
Totale 12.681
Nome #
Post-lumbar puncture headache: an adverse effect in multiple sclerosis work-up 1.916
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 248
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 190
Guillain-Barrè syndrome following COVID-19 vaccine mRNA-1273: a case report 176
Effect of alemtuzumab on fatigue, quality of life, and patient/caregiver-reported outcomes in relapsing-remitting multiple sclerosis-A real-world evidence study 173
Change over time of COVID-19 hospital presentation in Northern Italy 162
Impaired visual inhibition in migraine with aura. 147
Anti-cytokine autoantibodies in autoimmune diseases 147
Subcutaneous inverse vaccination with PLGA particles loaded with a MOG peptide and IL-10 decreases the severity of experimental autoimmune encephalomyelitis 144
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis 143
Cortical visuomotor interactions in Freezing of Gait: A TMS approach 142
Relationship between circulating CD4+ T lymphocytes and cognitive impairment in patients with Parkinson's disease 137
Insights into the protective role of immunity in neurodegenerative disease 135
Circulating extracellular vesicles in subarachnoid hemorrhage patients: characterization and cellular effects 134
Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia 133
Kappa free light chains could predict early disease course in multiple sclerosis 133
Calcium and glutamate involvement in activation of multiple sclerosis patient lymphocytes 130
Combined use of Kappa Free Light Chain Index and Isoelectrofocusing of Cerebro-Spinal Fluid in Diagnosing Multiple Sclerosis: Performances and Costs 129
Phenotypic heterogeneity of movement disorders due to intracranial calcifications with or without SLC20A2 mutations 126
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 126
A91V variation of the perforin gene in patients with multiple sclerosis 125
Abnormal response to glutamate of T lymphocytes from multiple sclerosis patients 124
Extracellular proteasome-osteopontin circuit regulates cell migration with implications in multiple sclerosis 124
Expanding the genetic spectrum of primary familial brain calcification due to SLC2OA2 mutations: a case series 124
Chronic obstructive pulmonary disease may complicate Alzheimer's disease: a comorbidity problem 123
K Index is a Reliable Marker of Intrathecal Synthesis, and an Alternative to IgG Index in Multiple Sclerosis Diagnostic Work-Up 123
Osteopontin Bridging Innate and Adaptive Immunity in Autoimmune Diseases 122
Cerebrospinal fluid levels of tissue inhibitor of metalloproteinase 1 are increased in subjects with mild cognitive impairment 121
Exploring serum and CSF Calcitonin Gene Related Peptide levels: A promising biomarker in multiple sclerosis? 119
A patient with autoimmune limb-girdle myasthenia, and a brief review of this treatable condition 118
Contribution of Rare and Low-Frequency Variants to Multiple Sclerosis Susceptibility in the Italian Continental Population 118
Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo 117
An investigation of the role of common and rare variants in a large italian multiplex family of multiple sclerosis patients 117
Polymorphisms of dopamine receptor genes and parkinson’s disease: Clinical relevance and future perspectives 116
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 115
Advances in Neuroimmunology: From Bench to Bedside 115
A case of progressive multifocal leukoencephalopathy after autologous bone marrow transplantation successfully treated with mirtazapine and cidofovir 115
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 114
Polymorphisms of dopamine receptor genes and risk of l-dopa–induced dyskinesia in parkinson’s disease 114
Cerebrospinal Tau levels as a predictor of early disability in multiple sclerosis 114
Short-term videoEEG: Review of a 3-year experience [Short-term videoEEG: Studio retrospettivo di 3 anni di esperienza clinica] 113
MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis 113
Nerve conduction, circulating osteopontin and taxane-induced neuropathy in breast cancer patients 113
Cerebrospinal fluid biomarkers and cognitive functions at multiple sclerosis diagnosis 113
ICOS gene haplotypes correlate with multiple sclerosis development and progression 111
Immune Response Modifications in the Genetic Forms of Parkinson’s Disease: What Do We Know? 111
Defective Fas-mediated T-cell apoptosis predicts acute onset CIDP 109
Complex pattern of convulsive syncope in glossopharyngeal neuralgia: video/EEG report and short review 108
Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies 108
The length of SNCA Rep1 microsatellite may influence cognitive evolution in Parkinson’s disease 107
Probiotics May Have Beneficial Effects in Parkinson's Disease: In vitro Evidence 107
Intrathecal kappa free light chains as markers for multiple sclerosis 107
The -346T polymorphism of the SH2D1A gene is a risk factor for development of autoimmunity/lymphoproliferation in males with defective Fas function 106
Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study 106
Antiphospholipid Syndrome and the Neurologist: From Pathogenesis to Therapy 105
Neuroinflammatory Pathways in the ALS-FTD Continuum: A Focus on Genetic Variants 104
Cerebrospinal Fluid Biomarkers in Progranulin Mutations Carriers 103
Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis 102
The Yin-Yang of osteopontin in nervous system diseases: Damage versus repair 102
A novel genetic prediction score in myoclonus-dystonia 100
IV lacosamide: Report of two cases of successful treatment of refractory status epilepticus [Utilizzo di lacosamide ev: Esperienza in due casi di stato di male epilettico refrattario] 100
Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk 100
Erratum: Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk (Cell (2019) 178(1) (262), (S0092867419306798), (10.1016/j.cell.2019.06.016)) 100
LRP10 genetic variants in familial Parkinson's disease and dementia with Lewy bodies: a genome-wide linkage and sequencing study 99
Prognostic Role of Visual Evoked Potentials in Non-Neuritic Eyes at Multiple Sclerosis Diagnosis 98
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells 98
The spectrum of movement disorders in chronic liver disease: A cross-sectional study 98
Intensive Rehabilitation Treatment in Early Parkinson's Disease: A Randomized Pilot Study With a 2-Year Follow-up 98
A nationwide retrospective analysis on the effect of immune therapies in patients with chronic inflammatory demyelinating polyradiculoneuropathy 97
Untangling Extracellular Proteasome-Osteopontin Circuit Dynamics in Multiple Sclerosis 97
CD4+ T-Cell Transcription Factors in Idiopathic REM Sleep Behavior Disorder and Parkinson’s Disease 97
Longitudinal Assessment of Transorbital Sonography, Visual Acuity, and Biomarkers for Inflammation and Axonal Injury in Optic Neuritis 96
Paraneoplastic neuromyelitis optica spectrum disorders: a case series 96
Early Predictors of Disability and Cognition in Multiple Sclerosis Patients: A Long-Term Retrospective Analysis 95
The spectrum of movement disorders in chronic liver disease: a cross-sectional study 95
Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline 94
Variations of the perforin gene in patients with multiple sclerosis 93
Osteopontin gene haplotypes correlate with multiple sclerosis development and progression 93
Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression 93
A very early onset of juvenile parkinsonism 92
Parkinson's disease patients have a complex phenotypic and functional Th1 bias: Cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients 92
Anticonvulsant Drugs and Cognitive Functions in Elderly Patients with Epilepsy 91
Osteopontin is increased in the cerebrospinal fluid of patients with early Alzheimer's disease and its levels correlate with cognitive deterioration 91
Transorbital Sonography and Visual Outcome for the Diagnosis and Monitoring of Optic Neuritis 91
LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patients 91
Candidate gene analysis of SPARCL1 gene in patients with multiple sclerosis 91
Holmes tremor caused by a natalizumab-related progressive multifocal leukoencephalopathy: a case report and brief review of the literature 91
Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens. 90
Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome. 89
Clinical relevance of single-subject brain metabolism patterns in amyotrophic lateral sclerosis mutation carriers 88
Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients: A Randomized Controlled Trial With 1-Year Follow-up 88
Exploiting PLGA-Based Biocompatible Nanoparticles for Next-Generation Tolerogenic Vaccines against Autoimmune Disease 88
Dopaminergic therapies modulate the T-CELL proteome of patients with Parkinson's disease. 87
Susac Syndrome: an uncommon cause of impaired vision 87
Relationship between [123I]FP-CIT SPECT data and peripheral CD4 + T cell profile in newly-diagnosed drug-naïve Parkinson's disease patients 86
New Insights into the Relationship between Nutrition and Neuroinflammation in Alzheimer's Disease: Preventive and Therapeutic Perspectives 86
Robotic gait training is not superior to conventional treadmill training in Parkinson's Disease: A single-blind randomized controlled trial 86
Intensive Rehabilitation Increases BDNF Serum Levels in Parkinsonian Patients: A Randomized Study 86
Role of the C-terminal fragment of osteopontin in multiple sclerosis 86
Serum vitamin d as a marker of impaired information processing speed and early disability in multiple sclerosis patients 86
Totale 12.997
Categoria #
all - tutte 104.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021255 0 0 0 0 0 0 0 0 0 15 180 60
2021/20221.236 69 36 131 137 57 18 127 22 120 47 178 294
2022/20232.607 205 138 136 27 118 183 85 101 1.448 18 98 50
2023/20241.203 77 52 114 48 203 23 210 70 27 13 108 258
2024/20252.953 65 47 200 96 63 217 299 213 741 208 249 555
2025/202610.919 443 339 676 1.476 983 655 1.528 1.670 2.460 689 0 0
Totale 22.373